4-(苄氧基)-3-氟苯甲醛 | 175968-61-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 4-(苄氧基)-3-氟苯甲醛
• 中文别名: 4-苄氧基-3-氟苯甲醛
• 英文名称: 4-(benzyloxy)-3-fluorobenzaldehyde
• 英文别名: 3-fluoro-4-[(phenylmethyl)oxy]benzaldehyde；3-fluoro-4-phenylmethoxybenzaldehyde
• CAS: 175968-61-3
• 化学式: C₁₄H₁₁FO₂
• 分子量: 230.239
• InChiKey: UHPCUBUGXLMORP-UHFFFAOYSA-N

物化性质

• 熔点：
  94-95 °C(Solv: dichloromethane (75-09-2); hexane (110-54-3))
• 沸点：
  371.5±27.0 °C(Predicted)
• 密度：
  1.211±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2913000090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  2-8°C，需保持充气状态。

反应信息

• 作为反应物：
  描述：

  4-(苄氧基)-3-氟苯甲醛 在 sodium tetrahydroborate 、 氯化亚砜 、 potassium hydroxide 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 9.0h， 生成 [4-(benzyloxy)-3-fluorophenyl]acetic acid
  参考文献：
  名称：

  EP3643703

  摘要：

  公开号：
• 作为产物：
  描述：

  3-氟-4-甲氧基苯甲醛 在 三溴化硼 、 sodium hydride 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 49.0h， 生成 4-(苄氧基)-3-氟苯甲醛
  参考文献：
  名称：

  Synthesis, biological activity and structure–activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells

  摘要：

  Insulin resistance is a complex altered metabolic condition characterized by impaired insulin signaling and implicated in the pathogenesis of serious human diseases, such as diabetes, obesity, neurodegenerative pathologies. In pursuing our aim to identify new agents able to improve cellular insulin sensitivity, we have synthesized new 4-[(5-arylidene-4-oxo-2-phenylimino/oxothiazolidin-3-yl)methyl] benzoic acids (5, 8) and evaluated their inhibitory activity towards human protein tyrosine phosphatases PTP1B, LMW-PTP and TCPTP, enzymes which are involved in the development of insulin resistance. Compounds 5 and 8 showed from moderate to significant selectivity toward PTP1B over both the highly homologous TCPTP and the two isoforms of human LMW-PTP. In addition, most of the tested compounds selectively inhibited LMW-PTP IF1 over the isoform IF2. Docking studies into the active sites of PTP1B and LMW-PTP aided the rationalization of the observed PTP inhibitory profile. Moreover, most tested compounds were capable to induce the insulin metabolic pathway in mouse C2C12 skeletal muscle cells by remarkably stimulating both IR beta phosphorylation and 2-deoxyglucose cellular uptake. (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.11.001

文献信息

• [EN] INDOLE DERIVATIVES AS HISTAMINE RECEPTOR ANTAGONISTS<br/>[FR] DERIVES D'INDOLE UTILISES COMME ANTAGONISTES DU RECEPTEUR DE L'HISTAMINE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2005123716A1

  公开（公告）日：2005-12-29

  The present invention relates to compounds of formula (I) wherein X, R1, R2, R3, R4 and R5 are as defined in the description and claims, and pharmaceutically acceptable salts thereof, to the preparation of such compounds and pharmaceutical compositions containing them. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.

  本发明涉及式（I）的化合物，其中X、R1、R2、R3、R4和R5如描述和权利要求中所定义，并其药学上可接受的盐，以及制备这些化合物和含有它们的药物组合物。这些化合物对于治疗和/或预防与H3受体调节相关的疾病是有用的。
• NOVEL ANALOGUES OF EPICATECHIN AND RELATED POLYPHENOLS
  申请人：SPHAERA PHARMA PVT. LTD.

  公开号：US20160039781A1

  公开（公告）日：2016-02-11

  The present invention provides novel analogues of epicatechin and related polyphenols, their variously functionalized derivatives, process for preparation of the same, composition comprising these compounds and their method of use.

  本发明提供了表儿茶素及相关多酚的新颖类似物，它们的各种官能化衍生物，以及它们的制备方法、包含这些化合物的组合物和它们的使用方法。
• [EN] PIM KINASE INHIBITOR COMPOSITIONS AND USES THEREOF<br/>[FR] COMPOSITIONS D'INHIBITEUR DE KINASE PIM ET UTILISATIONS ASSOCIÉES
  申请人：SNAP BIO INC

  公开号：WO2020223306A1

  公开（公告）日：2020-11-05

  This disclosure relates to compounds and compositions useful as inhibitors of PIM kinases. Also provided are methods of synthesis and methods of use of PIM inhibitors in treating individuals suffering from cancerous malignancies.

  这份披露涉及到作为PIM激酶抑制剂的化合物和组合物，同时提供了合成方法和在治疗患有癌症恶性肿瘤的个体中使用PIM抑制剂的方法。
• [EN] NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMA AGONISTS<br/>[FR] NOUVEAUX COMPOSES 2-ARYLTHIAZOLE UTILISES COMME AGONISTES DES RECEPTEURS PPARALPHA ET PPARGAMMA
  申请人：HOFFMANN LA ROCHE

  公开号：WO2004020420A1

  公开（公告）日：2004-03-11

  The present invention relates to compounds of formula (I) wherein Rl to R10, X, Y and n are as defined in the description and claims, and pharmaceutically acceptable salts and esters thereof. The compounds are useful for the treatment of diseases such as diabetes.

  本发明涉及式(I)的化合物，其中R1至R10、X、Y和n如描述和权利要求中所定义，并且其药学上可接受的盐和酯。这些化合物对于治疗疾病如糖尿病是有用的。
• LIQUID-CRYSTALLINE COMPOUNDS AND LIQUID-CRYSTALLINE MEDIA
  申请人：JANSEN Axel

  公开号：US20110233466A1

  公开（公告）日：2011-09-29

  The present invention relates to liquid-crystalline compounds having at least three fluorine-substituted benzene rings, a terminal trifluoromethyl group and at least one —CF 2 O— bridge. The invention also relates to liquid-crystalline media prepared therewith and to liquid-crystal display devices (LC displays) containing these media.

  本发明涉及具有至少三个氟代苯环、末端三氟甲基基团和至少一个—CF2O—桥的液晶化合物。该发明还涉及由此制备的液晶介质以及含有这些介质的液晶显示器（LC显示器）。